CureusLuseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational StudyIntroduction: Glucose fluctuations have been implicated in the development of diabetic macroangiopathy. Sodium-glucose cotransporter 2….6 hours ago

CureusLuseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational StudyIntroduction: Glucose fluctuations have been implicated in the development of diabetic macroangiopathy. Sodium-glucose cotransporter 2….6 hours ago

Related posts

Kyoto University unveils noninvasive assessment for diabetes

Association of Neutrophil-to-Lymphocyte Ratio With Early Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus

Dexcom unveils Type 2 diabetes CGM data at ATTD